Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial.

Autor: Ma RC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China., Del Prato S; Section of Diabetes, Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy., Gallwitz B; Department of Medicine IV, University Hospital Tübingen, Tübingen, Germany., Shivane VK; Department of Endocrinology, Seth G. S. Medical College and KEM Hospital, Mumbai, India., Lewis-D'Agostino D; Boehringer Ingelheim Pharmaceuticals Inc., Connecticut, USA., Bailes Z; Boehringer Ingelheim Ltd, Bracknell, UK., Patel S; Boehringer Ingelheim Ltd, Bracknell, UK., Lee J; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., von Eynatten M; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Di Domenico M; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Ross SA; University of Calgary, LMC Endocrinology Centers, Alberta, Canada.

Publikováno v: Journal of diabetes investigation [J Diabetes Investig] 2017 Sep 16. Date of Electronic Publication: 2017 Sep 16.